Oncogene Proteins, Fusion

"Oncogene Proteins, Fusion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The GENETIC TRANSLATION products of the fusion between an ONCOGENE and another gene. The latter may be of viral or cellular origin.

Descriptor ID	D015514
MeSH Number(s)	D12.776.602.500.500 D12.776.624.664.500
Concept/Terms	Oncogene Proteins, Fusion Oncogene Proteins, Fusion Fusion Oncogene Proteins Proteins, Fusion Oncogene Oncogene Proteins, Chimeric Fusion Proteins, Oncogene Oncogene Fusion Proteins Proteins, Oncogene Fusion Chimeric Oncogene Proteins Proteins, Chimeric Oncogene Chimeric Proteins, Oncogene Oncogene Chimeric Proteins Proteins, Oncogene Chimeric

Below are MeSH descriptors whose meaning is more general than "Oncogene Proteins, Fusion".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Mutant Proteins [D12.776.602]
Mutant Chimeric Proteins [D12.776.602.500]
Oncogene Proteins, Fusion [D12.776.602.500.500]
Neoplasm Proteins [D12.776.624]
Oncogene Proteins [D12.776.624.664]
Oncogene Proteins, Fusion [D12.776.624.664.500]

Below are MeSH descriptors whose meaning is related to "Oncogene Proteins, Fusion".

Below are MeSH descriptors whose meaning is more specific than "Oncogene Proteins, Fusion".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Oncogene Proteins, Fusion" by people in this website by year, and whether "Oncogene Proteins, Fusion" was a major or minor topic of these publications.

Bar chart showing 40 publications over 19 distinct years, with a maximum of 4 publications in 2008 and 2014 and 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	1	2
1999	1	0	1
2002	1	0	1
2003	1	0	1
2004	2	0	2
2006	3	0	3
2007	1	0	1
2008	3	1	4
2009	2	1	3
2011	0	1	1
2012	2	1	3
2013	0	1	1
2014	3	1	4
2015	2	0	2
2016	1	0	1
2017	3	1	4
2018	1	1	2
2021	1	2	3
2022	0	1	1

Below are the most recent publications written about "Oncogene Proteins, Fusion" by people in Profiles.

French CA, Cheng ML, Hanna GJ, DuBois SG, Chau NG, Hann CL, Storck S, Salgia R, Trucco M, Tseng J, Stathis A, Piekarz R, Lauer UM, Massard C, Bennett K, Coker S, Tontsch-Grunt U, Sos ML, Liao S, Wu CJ, Polyak K, Piha-Paul SA, Shapiro GI. Report of the First International Symposium on NUT Carcinoma. Clin Cancer Res. 2022 06 13; 28(12):2493-2505.

View in: PubMed
van der Kouwe E, Heller G, Czibere A, Pulikkan JA, Agreiter C, Castilla LH, Delwel R, Di Ruscio A, Ebralidze AK, Forte M, Grebien F, Heyes E, Kazianka L, Klinger J, Kornauth C, Le T, Lind K, Barbosa IAM, Pemovska T, Pichler A, Schmolke AS, Schweicker CM, Sill H, Sperr WR, Spittler A, Surapally S, Trinh BQ, Valent P, Vanura K, Welner RS, Zuber J, Tenen DG, Staber PB. Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter. Blood. 2021 10 14; 138(15):1345-1358.

View in: PubMed
Massart J, Sj?gren RJO, Egan B, Garde C, Lindgren M, Gu W, Ferreira DMS, Katayama M, Ruas JL, Barr?s R, O'Gorman DJ, Zierath JR, Krook A. Endurance exercise training-responsive miR-19b-3p improves skeletal muscle glucose metabolism. Nat Commun. 2021 10 12; 12(1):5948.

View in: PubMed
Reid SE, Patel SA. Myocarditis, kidney injury, and hypereosinophilia: FIP1L1-PDGFRA-positive myeloid/lymphoid neoplasm with eosinophilia. Blood. 2021 09 23; 138(12):1086.

View in: PubMed
Averill AM, Rehman HT, Charles JW, Dinh TA, Danyal K, Verschraegen CF, Stein GS, Dostmann WR, Ramsey JE. Inhibition of the chimeric DnaJ-PKAc enzyme by endogenous inhibitor proteins. J Cell Biochem. 2019 08; 120(8):13783-13791.

View in: PubMed
Bean GR, Krings G, Otis CN, Solomon DA, Garc?a JJ, van Zante A, Camelo-Piragua S, van Ziffle J, Chen YY. CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast. Histopathology. 2019 Feb; 74(3):463-473.

View in: PubMed
Pulikkan JA, Hegde M, Ahmad HM, Belaghzal H, Illendula A, Yu J, O'Hagan K, Ou J, Muller-Tidow C, Wolfe SA, Zhu LJ, Dekker J, Bushweller JH, Castilla LH. CBF?-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia. Cell. 2018 06 28; 174(1):172-186.e21.

View in: PubMed
Giunchi F, Ciccarese C, Montironi R, Scarpelli M, Lopez-Beltran A, Cheng L, Moch H, Massari F, Fiorentino M. Urinary Biomarkers for Prostate Cancer. Curr Drug Metab. 2017 Oct 16; 18(8):723-726.

View in: PubMed
Zaidi SK, Perez AW, White ES, Lian JB, Stein JL, Stein GS. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells. Oncotarget. 2017 Jun 20; 8(25):39994-40005.

View in: PubMed
Gasparrini S, Cimadamore A, Mazzucchelli R, Scarpelli M, Massari F, Raspollini MR, Galosi AB, Lopez-Beltran A, Cheng L, Montironi R. Pathology and molecular updates in tumors of the prostate: towards a personalized approach. Expert Rev Mol Diagn. 2017 08; 17(8):781-789.

View in: PubMed

People

Explore

Similar Concepts

Top Journals